Platform analyzes trading cards across 47 inspection points in under 60 seconds with 92.8% accuracy We started ...

New TorchPass solution addresses a multi-million dollar challenge with AI infrastructure; uses Live GPU Migration to ...

Application security solution provider White Source Ltd., also known as Mend.io, today launched System Prompt Hardening, a dedicated capability designed to detect issues within the hidden instructions ...

EX.IO ("EX.IO"), a leading licensed and compliant virtual asset trading platform in Hong Kong has recently successfully made available the Finloop USD Instant Digital Liquidity (FUIDL). The ...

Unlike standalone AI tools that provide instructions for what to do, Apollo's AI Assistant is embedded directly into core workflows and actually does the work. Now, sales, marketing, and revenue teams ...

In February 2026, after the U.S. Department of Justice released millions of files from its investigation into the late sex offender Jeffrey Epstein, a claim (archived) circulated online that Attorney ...

This is an "upgrade" package for PX4 Firmware that defines a certain I/O structure for control system development and integration through SIMULINK. The focus here is to provide an integration layer ...

A U.S. appeals court has upheld a temporary restraining order that prevents OpenAI and Jony Ive's new hardware venture from using the name "io" for products similar to those planned by AI audio ...

The legal fight between OpenAI and iyO took another turn, following a decision by the 9th Circuit Court of Appeals. Here are the details. Earlier this year, as soon as OpenAI announced that it had ...

IO-Link uses standard unshielded cables to enable real-time data exchange between sensors, actuators and control systems, replacing simple on/off signals with detailed device performance and ...

IO Biotech has resorted to halving its workforce after the FDA knocked back its plans to seek approval for its cancer vaccine. The therapeutic vaccine, called Cylembio, failed to beat Merck & Co.’s ...

IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma trial, but the company remains hopeful of a path to approval. The New ...